The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

N.D. Prins, W.A. van der Flier, D.L. Knol, N.C. Fox, H.R. Brashear, J.S. Nye, F. Barkhof, P. Scheltens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article number47
JournalAlzheimer's Research & Therapy
Issue number4
Publication statusPublished - 2014

Cite this